How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations

Journal of Postgraduate Medicine

Volumn 52, Issue 4, 2006, Pages 321-324

  Chatterjee, S ^a   Perignon, J L ^b   Van Marck, E ^a   Druilhe, P ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b INSTITUT PASTEUR   (France)

Author keywords

Grammomys; Host parasite interactions; Irradiated sporozoites; Laboratory models; Plasmodium; Vaccine

Indexed keywords

MALARIA VACCINE; SPOROZOITE VACCINE;

BIOLOGICAL MODEL; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; HOST; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INBRED STRAIN; INNATE IMMUNITY; IRRADIATION; MALARIA; NONHUMAN; PARASITE IMMUNITY; PARASITOSIS; PLASMODIUM BERGHEI; PRIMATE; RELIABILITY; RODENT; SHORT SURVEY; VACCINE PRODUCTION; ZOONOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALARIA; MALARIA VACCINES; MICE; PLASMODIUM; RATS; REPRODUCIBILITY OF RESULTS; SPOROZOITES;

EID: 33845241282     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (47)

1. Nussenzweig RS, Vanderberg J, Spitalny GL, Rivera CI, Orton C, Most H. Sporozoite induced immunity in mammalian malaria. A review. Am J Trop Med Hyg 1972;21:722-8.
2. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002;185:1155-64.
3. Orjih AU, Cochrane AH, Nussenzweig RS. Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans R Soc Trop Med Hyg 1982;76:57-61.
4. Jaffe RI, Lowell GH, Gordon DM. Differences in susceptibility among mouse strains to infection with Plasmodium berghei (ANKA clone) sporozoites and its relationship to protection by gamma-irradiated sporozoites. Am J Trop Med Hyg 1990;42:309-13.
5. Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, et al. Successful immunization of humans with irradiated malaria sporozoites: Humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 1991;45:539-47.
6. Edelman R, Hoffman SL, Davis JR, Beier M, Sztein MB, Losonsky G, et al. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. J Infect Dis 1993;168:1066-70.
7. Bray RS. Vaccination against Plasmodium falciparum: A negative result. Trans R Soc Trop Med Hyg 1976;70:258.
8. Vincke IH, Lips M. Un nouveau plasmodium d'un rongeur sauvage du Congo, Plasmodium berghei N.Sp. Ann Soc Belge Méd Trop 1948;25:97-102.
9. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE. Immune responses to asexual blood-stages of malaria parasites. Curr Mol Med 2006;6:187-203.
10. Chatterjee S, Ngonseu E, Van Overmeir C, Correwyn A, Druilhe P, Wéry M. Rodent malaria in the natural host - irradiated sporozoites of Plasmodium berghei induce liver-stage specific immune responses in the natural host Grammomys surdaster and protect immunized Grammomys against P. berghei sporozoite challenge. Afr J Med Med Sci 2001;30:25-33.
11. Druilhe P. Immunity to liver stages. In: Malaria. Parasite biology. Pathogenesis and Protection (Sherman IW, editor) pp. 513-543. American Society of Microbiology: 1998.
12. Alloueche A, Milligan P, Conway DJ, Pinder M, Bojang K, Doherty T, et al. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am J Trop Med Hyg 2003;68:97-101.
13. Khan ZM, Vanderberg JP. Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and P. yoelii sporozoites. Infect Immun 1991;59:2529-34.
14. Khan ZM, Vanderberg JP. Eosinophil-rich, granulomatous inflammatory response to Plasmodium berghei hepatic schizonts in non-immunized mice is age-related. Am J Trop Med Hyg 1991;45:190-201.
15. Vanderberg JP, Khan ZM, Stewart MJ. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites. J Parasitol 1993;79:763-7.
16. Meis JF, Jap PH, Hollingdale MR, Verhave JP. Cellular response against exoerythrocytic forms of Plasmodium berghei in rats. Am J Trop Med Hyg 1987;37:506-10.
17. Bafort JM. The biology of rodent malaria with particular reference to Plasmodium vinckei vinckei rodhain. Ann Soc Belge Méd Trop 1971;51:5-203.
18. Scheller LF, Wirtz RA, Azad AF. Susceptibility of different strains of mice to hepatic infections with Plasmodium berghei. Infect Immun 1994;62:4844-7.
19. Londono JA, Sedegah M, Charoenvit Y, Beaudoin RL, Druilhe P. Antigenic analysis of Plasmodium yoelii liver stages by fluorescence antibody assays. Trop Med Parasitol 1991;42:381-5.
20. Scheller LF, Azad AF. Maintenance of protective immunity against malaria by persistent hepatic stages derived from irradiated sporozoites. Proc Natl Acad Sci USA 1995;92:4066-8.
21. Scheller LF, Stump KC, Azad AF. Plasmodium berghei: Production and quantitation of hepatic stages derived from irradiated sporozoites in rats and mice. J Parasitol 1995;81:58-62.
22. Khan ZM, Ng C, Vanderberg JP. Early hepatic stages of Plasmodium berghei: Release of circumsporozoite protein and host cellular inflammatory response. Inf Imm 1992;60:264-70.
23. Hoffman SL. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 1989;244:1078-81.
24. Rollinson D, Southgate VR. The genus Schistosoma: A taxonomic appraisal. In The Biology of Schistosomes (Rollinson D, Simpson AJ, editors). Academic Press: 1987. p. 1-49.
25. Minard P, Dean DA, Jacobson RH, Vannier WE, Murrell KD. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg 1978;27:76-86.
26. Majid AA, Marshall TF, Hussein MF, Busharo HO, Taylor MG, Nelson GS, et al. Observations on cattle schistosomiasis in the Sudan, a study in comparative medicine. III Field testings of an irradiated schistosoma bovis vaccine. Am J Trop Med Hyg 1980;29:452-5.
27. Wynn TA, Oswald IP, Eltoum IA, Caspar P, Lowenstein CJ, Lewis FA, et al. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 1994;153:5200-9.
28. Eberl M, Langermans JA, Frost PA, Vervenne RA, van Dam GJ, Deelder AM, et al. Cellular and humoral immune responses and protection against schistosomes induced by a radiation - Attenuated vaccine in chimpanzees. Inf Imm 2001;69:5352-62.
29. Capron A, Capron M, Dombrowicz D, Riveau G. Vaccine strategies against schistosomiasis: From concepts to clinical trials. Int Arch Allergy Immunol 2001;124:9-15.
30. Ross AG, Sleigh AC, Li Y, Davis GM, Williams GM, Jiang Z, et al. Schistosomiasis in the People's Republic of China: Prospects and challenges for the 21rst century. Clin Microbiol Rev 2001;14:270-95.
31. Dean DA. Schistosoma and related genera: Acquired resistance in mice. Exp Parasitol 1983;55:1-104.
32. Warren KS. The contribution of worm burden and host response to the development of hepato-splenic schistosomiasis mansoni in mice. Am J Trop Med Hyg 1963;12:34-9.
33. Smythies LE, Pemberton RM, Coulson PS, Mountford AP, Wilson RA. T-cell-derived cytokines associated with pulmonary immune mechanisms in mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol 1992;148:1512-8.
34. Betts CJ, Wilson RA. Th1 cytokine mRNA expression dominates in the skindraining lymph nodes of C57BL6 mice following vaccination with irradiated Schistosoma mansoni cercariae, but is down-regulated upon challenge infection. Immunol 1998;93:49-54.
35. Pearce EJ, Sher A. Functional dichotomy in the CD4+ T cell response to Schistosoma mansoni. Exp Parasitol 1991;73:110-6.
36. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-5.
37. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;21:2679-86.
38. Dunne DW, Butterworth AE, Fulford AJ, Kariuki HC, Langley JG, Ouma JH, et Chatterjee, et al.: Natural versus artificial model al. Immunity after treatment of human schistosomiasis: Association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-94.
39. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996;14:181-4.
40. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002;419:498-511.
41. Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, Nusskern DR, et al. The genome sequence of the malaria mosquito Anopheles gambiae. Science 2002;298:129-49.
42. Carlton JM, Angiuoli SV, Suh BB, Kooij TW, Pertea M, Silva JC, et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002;419:512-9.
43. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002;419:520-6.
44. Maher BA. The hopes and realities of the Plasmodium falciparum genome. The Scientist 2002;16:24-7.
45. Chauhan VS, Bhardwaj D. Current status of malaria vaccine development. Adv Biochem Eng Biotechnol 2003;84:143-82.
46. Daubersiers P, Thomas AW, Millet P, Brahimi K, Langermans JA, Ollomo B, et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med 2000;6:1258-63.
47. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, Rinfret A, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001;8:927-33.